A randomized trial of vertebroplasty for osteoporotic spinal fractures

David F. Kallmes, Bryan A. Comstock, Patrick J. Heagerty, Judith A. Turner, David J. Wilson, Terry H. Diamond, Richard Edwards, Leigh A. Gray, Lydia Stout, Sara Owen, William Hollingworth, Basavaraj Ghdoke, Deborah J. Annesley-Williams, Stuart H. Ralston, Jeffrey G. Jarvik

Research output: Contribution to journalArticle

968 Scopus citations

Abstract

BACKGROUND: Vertebroplasty is commonly used to treat painful, osteoporotic vertebral compression fractures. METHODS: In this multicenter trial, we randomly assigned 131 patients who had one to three painful osteoporotic vertebral compression fractures to undergo either vertebroplasty or a simulated procedure without cement (control group). The primary outcomes were scores on the modified Roland-Morris Disability Questionnaire (RDQ) (on a scale of 0 to 23, with higher scores indicating greater disability) and patients' ratings of average pain intensity during the preceding 24 hours at 1 month (on a scale of 0 to 10, with higher scores indicating more severe pain). Patients were allowed to cross over to the other study group after 1 month. RESULTS: All patients underwent the assigned intervention (68 vertebroplasties and 63 simulated procedures). The baseline characteristics were similar in the two groups. At 1 month, there was no significant difference between the vertebroplasty group and the control group in either the RDQ score (difference, 0.7; 95% confidence interval [CI], -1.3 to 2.8; P = 0.49) or the pain rating (difference, 0.7; 95% CI, -0.3 to 1.7; P = 0.19). Both groups had immediate improvement in disability and pain scores after the intervention. Although the two groups did not differ significantly on any secondary outcome measure at 1 month, there was a trend toward a higher rate of clinically meaningful improvement in pain (a 30% decrease from baseline) in the vertebroplasty group (64% vs. 48%, P = 0.06). At 3 months, there was a higher crossover rate in the control group than in the vertebroplasty group (43% vs. 12%, P<0.001). There was one serious adverse event in each group. CONCLUSIONS: Improvements in pain and pain-related disability associated with osteoporotic compression fractures in patients treated with vertebroplasty were similar to the improvements in a control group. (ClinicalTrials.gov number, NCT00068822.)

Original languageEnglish (US)
Pages (from-to)569-579
Number of pages11
JournalNew England Journal of Medicine
Volume361
Issue number6
DOIs
StatePublished - Aug 6 2009

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'A randomized trial of vertebroplasty for osteoporotic spinal fractures'. Together they form a unique fingerprint.

  • Cite this

    Kallmes, D. F., Comstock, B. A., Heagerty, P. J., Turner, J. A., Wilson, D. J., Diamond, T. H., Edwards, R., Gray, L. A., Stout, L., Owen, S., Hollingworth, W., Ghdoke, B., Annesley-Williams, D. J., Ralston, S. H., & Jarvik, J. G. (2009). A randomized trial of vertebroplasty for osteoporotic spinal fractures. New England Journal of Medicine, 361(6), 569-579. https://doi.org/10.1056/NEJMoa0900563